Trade wars, China’s slowdown, erratic stock markets: The outlook is getting grimmer for an increasing number of companies across the globe.

Demand in the region fizzled late in 2018 due to a combination of emissions-testing bottlenecks and economic headwinds — and more pain could lie ahead.

Some U.S. domestic companies have benefited from the tariffs placed on imports from China by President Trump, while others can be classified as collateral damage.

In the nascent world of global pot investing and sourcing, assets can be hard to document — but may hold enormous rewards.

After four years of planning, Tesla Inc. is finally breaking ground on its $5bn factory in the world’s biggest auto market. But the timing couldn’t be more inauspicious.

These companies are exploring manufacturing options outside of China as a result of tariffs and the trade war, according to Bloomberg.

U.S. and Chinese officials are set to begin trade negotiations on Monday in the hope of reaching a deal during a 90-day truce between President Donald Trump and Xi Jinping.

The U.S. hasn’t done enough to counter the use of technology transfers and supply chain infiltration from countries like China, according to two U.S. senators.

China’s plan to drive down generic drug prices through a centralized bulk procurement program is set to redraw the industry.